JESSICA OXENDINE: Open Payments
NPI 1144800491 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 10 payments from 8 companies in 2025. Trend: 2023 $138 · 2024 $228 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: ELIQUIS, Jornay PM, XIFAXAN, The Cologuard Plus Collection Kit, Ozempic, Cologuard Collection Kit, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across FL — which companies pay providers there.
